Several studies demonstrate that inflammation affects body odor. Volatile signals associated with inflammation induced by pyrogens like LPS are detectable both by conspecifics and chemical analyses. However, little is known about the mechanisms which translate detection of a foreign molecule or pathogen into a unique body odor, or even how unique that odor may be. Here, we utilized C57BL/6J trained mice to identify the odor of LPS-treated conspecifics to investigate potential pathways between LPS-induced inflammation and changes in body odor, as represented by changes in urine odor. We hypothesized that the change in volatile metabolites could be caused directly by the pro-inflammatory cytokine response mediated by TNF or IL-1b, or by the compensatory anti-inflammatory response mediated by IL-10. We found that trained biosensors generalized learned LPS-associated odors to TNF-induced odors, but not to IL-1b or IL-10-induced odors. Analyses of urine volatiles using headspace gas chromatography revealed distinct profiles of volatile compounds for each treatment. Instrumental discrimination relied on a mixture of compounds, including 2-sec-butyl-4,5-dihydrothiazole, cedrol, nonanal, benzaldehyde, acetic acid, 2-ethyl-1-hexanol, and dehydro-exo-brevicomin. Although interpretation of LDA modeling differed from behavioral testing, it does suggest that treatment with TNF, IL-1b, and LPS can be distinguished by their resultant volatile profiles. These findings indicate there is information found in body odors on the presence of specific cytokines. This result is encouraging for the future of disease diagnosis via analysis of volatiles.
Introduction
Body odors often contain information about the physiological state of the producer. In many species, including mice, body odor contains information on age, sex, genetics, diet, reproductive status, dominance, and health (Kimball et al., 2014 (Kimball et al., , 2016a Kwak et al., 2008 Kwak et al., , 2010 Novotny, 2003; Olsson et al., 2014; Osada et al., 2008; Penn and Potts, 1998) . The ability to detect illness or infection in conspecifics has obvious potential advantages. Evidence indicates odor cues allow this detection in multiple species, especially rodents (Arakawa et al., 2011; Boillat et al., 2015; Penn and Potts, 1998) . For example, female mice demonstrate reduced attraction to the odors of male conspecifics infected with parasites or a respiratory virus (Kavaliers and Colwell, 1995; Kavaliers et al., 1998; Penn et al., 1998) . Treatment of rats with lipopolysaccharide (LPS) or IL-1b results in avoidance by healthy conspecifics (Arakawa et al., 2011) . However, pretreatment with the antiinflammatory cytokine IL-10 blocked production of the aversive odor (Arakawa et al., 2010) . These findings suggest that cytokines serve as mediators of disease-induced odors. It is unclear, however, which cytokines specifically contribute to disease-related odors and how they impact the volatile metabolome as a whole.
Cytokine responses to inflammatory stimuli such as pathogens often represent a complex series of events. When faced with a common pathogen associated molecular pattern (PAMP) like LPS, there is rapid production of pro-inflammatory cytokines, most notably TNF and IL-1b (Bradley, 2008; Zuckerman et al., 1991) . LPS rapidly induces TNF, which induces its own production in macrophages (Vassalli, 1992) . TNF also induces production of IL1b in leukocytes (Dinarello et al., 1986) , which must be processed by an activated inflammasome before it can be secreted (Burm et al., 2015) . Both cytokines activate the vascular epithelium, induce the febrile response, and aid in the recruitment of effector immune cells. TNF also activates the respiratory burst in phagocytes and increases vascular permeability (Bradley, 2008) . Following shortly after the inflammatory response is a compensatory anti-inflammatory response, primarily regulated by the cytokine IL-10 (Bone, 1996; Moore et al., 2001 ). IL-10 inhibits production of IL-1b, TNF, IL-6, and numerous other inflammatory cytokines
